Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases

References

• Thomas CFJ, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350(24):2487–98.
   PubMed Web of Science ®Google Scholar
• Thomas CFJ, Limper AH. Current insights into the biology and pathogenesis of pneumocystis pneumonia. Nat Rev Microbiol. 2007;5(4):298–308.
   PubMed Web of Science ®Google Scholar
• Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum. 1999;42(4):780–9.
   PubMed Web of Science ®Google Scholar
• Phair J, Mufioz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med. 1990;322(3):161–5.
   PubMed Web of Science ®Google Scholar
• Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, et al. Pneumocystis carinii pneumonia: a compari-son between patients with the acquired immunodeficiency syn-drome and patients with other immunodeficiencies. Ann Intern Med. 1984;100(5):663–71.
   PubMed Web of Science ®Google Scholar
• Thomas CFJ, Limper AH. Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome. Semin Respir Infect. 1998;13(4): 289–95.
   PubMedGoogle Scholar
• Kelley CF, Checkley W, Mannino DM, Franco-Paredes C, Del Rio C, Holguin F. Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii pneumonia in the United States (1986 to 2005). Chest. 2009;136(1):190–7.
   Google Scholar
• Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA. 1992;267(6):832–7.
   Google Scholar
• Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associ-ated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996;71(1):5–13.
   PubMed Web of Science ®Google Scholar
• Limper AH, Offord KP, Smith TF, Martin WJ. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis. 1989;140(5): 1204–9.
   Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.
   PubMed Web of Science ®Google Scholar
• Zaman MK, Wooten OJ, Suprahmanya B, Ankobiah W, Finch PJ, Kamholz SL. Rapid noninvasive diagnosis of Pneumocystis carinii from induced liquefied sputum. Ann Intern Med. 1988;109(1):7–10.
   PubMed Web of Science ®Google Scholar
• Cruciani M, Marcati P, Malena M, Bosco 0, Serpelloni G, Mengoli C. Meta-analysis of diagnostic procedures for Pneu-mocystis carinii pneumonia in HIV-1-infected patients. Eur Respir J. 2002;20(4):982–9.
   Google Scholar
• Saito K, Nakayamada S, Nakano K, Tokunaga M, Tsujimura S, Nakatsuka K, et al. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheu-matic diseases. Rheumatology (Oxford). 2004;43(4):479–85.
   PubMed Web of Science ®Google Scholar
• Kameda H, Tokuda H, Sakai F, Johkoh T, Mori S, Yoshida Y, et al. Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of pneu-mocystis pneumonia in Japan revealed by a multicenter study. Intern Med 2011;50(4):305–13.
   PubMed Web of Science ®Google Scholar
• Komano Y, Harigai M, Koike R, Sugiyama H, Ogawa J, Saito K, et al. Pneumocystis jiroveci pneumonia in patients with rheu-matoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients. Arthritis Rheum. 2009;61(3):305–12.
   PubMed Web of Science ®Google Scholar
• Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, Takeuchi T, et al. Serum indicators for the diagnosis of pneu-mocystis pneumonia. Chest. 2007;131(4):1173–80.
   PubMed Web of Science ®Google Scholar
• Tokuda H, Sakai F, Yamada H, Johkoh T, Imamura A, Dohi M, et al. Clinical and radiological features of pneumocystis pneu-monia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study. Intern Med. 2008;47(10):915–23.
   PubMed Web of Science ®Google Scholar
• Ogawa J, Harigai M, Nagasaka K, Nakamura T, Miyasaka N. Pre-diction of and prophylaxis against pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy. Mod Rheumatol. 2005;15(2):91–6.
   Google Scholar
• Iikuni N, Kitahama M, Ohta S, Okamoto H, Kamatani N, Nish-inarita M. Evaluation of pneumocystis pneumonia infection risk factors in patients with connective tissue disease. Mod Rheu-matol. 2006;16(5):282–8.
   Google Scholar
• Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev. 2004;17(4): 770–82. Table of contents.
   Google Scholar
• Fishman JA. Prevention of infection caused by Pneumocystis carinii in transplant recipients. Clin Infect Dis. 2001;33(8):1397–405.
   PubMedGoogle Scholar
• The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumo-cystis Pneumonia. Consensus statement on the use of cortico-steroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990; 323(21): 1500–1504.
   PubMedGoogle Scholar
• Bozzette SA, Sattler FR, Chiu J, Wu AW, Gluckstein D, Kemper C, et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med. 1990;323(21):1451–7.
   Google Scholar
• Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest. 1998;113(5):1215–24.
   Google Scholar
• Mori S, Imamura F, Kiyofuji C, Ito K, Koga Y, Honda I, et al. Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody. Mod Rheu-matol. 2006;16(1):58–62.
   PubMedGoogle Scholar
• Mori S, Cho I, Ichiyasu H, Sugimoto M. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy. Mod Rheumatol. 2008;18(3):240–6.
   PubMedGoogle Scholar
• Stenger AA, Houtman PM, Bruyn GA, Eggink HF, Pasma HR. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis. Scand J Rheu-matol. 1994;23(1):51–3.
   Google Scholar
• Kaneko Y, Suwa A, Ikeda Y, Hirakata M. Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the liter-ature. Mod Rheumatol. 2006;16(1):36–8.
   PubMedGoogle Scholar
• Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia. Arthritis Rheum. 2006;54:628–34.
   PubMed Web of Science ®Google Scholar